Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
UK forecast to face weaker growth and higher inflation from Iran war - 2'Senseless violence' erupts at Christmas tree lighting; 4 injured
- 3From Modesty to Administration: Self-improvement in Interactive abilities
- 4Mount Everest Climbers 'Poisoned' by Guides Prompting Mass Helicopter Rescues in $20 Million Insurance Fraud Scheme, Police Say
- 5Four Dead in Last Month From Animal Attacks in Nepal
- Weeks-Long Australian LNG Outage Will Further Tighten Supply
- What happened to Eleven after the ambiguous 'Stranger Things' series finale? Millie Bobby Brown knows — but 'swore herself to secrecy'
- Instructions to Discuss Successfully with Your Auto Collision Lawyer
- Kona SUV: Exploring the Future with Hyundai's Visionary Hybrid
- Pick Your Favored kind of books
- Saturn shines with the waxing moon at sunset on Nov. 29
- EU waters down plans to end new petrol and diesel car sales by 2035
- Israeli archaeologists launch project to trace origins of ancient pottery
- The Best 15 Applications for Efficiency and Association
